Evidence map›Paper›PMID 23863936›Full record

ArticleNature2013

Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence.

Aparna Venkatraman, Xi C He, Joanne L Thorvaldsen, Ryohichi Sugimura, John M Perry, Fang Tao, Meng Zhao, Matthew K Christenson, Rebeca Sanchez, Jaclyn Y Yu and 8 more

Abstract read
In one paragraph

Article in Nature, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 1 pooled it
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 1 synthesis or guideline pooled it, 292 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Hepatoblastoma.Nature reviews. Disease primers · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. The role of IGF/IGF-1R signaling in the regulation of cancer stem cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Association ofMolecular genetics and metabolism reports · 2024
    Article
  18. Article
  19. Review
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Aparna VenkatramanStowers Institute for Medical Research, Kansas City, Missouri 64110, USA.
Xi C He
Joanne L Thorvaldsen
Ryohichi Sugimura
John M Perry
Fang Tao
Meng Zhao
Matthew K Christenson
Rebeca Sanchez
Jaclyn Y Yu
Lai Peng
Jeffrey S Haug
Ariel Paulson
Hua Li
Xiao-bo Zhong
Thomas L Clemens
Marisa S Bartolomei
Linheng Li
Stowers Institute for Medical Research · USUniversity of Kansas Medical Center · USUniversity of Pennsylvania · USJohns Hopkins University · USVall d'Hebron Institut de Recerca · ES

Funding

SEQUENCES CONTROLLING H19 GENE IMPRINTINGR01GM051279 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1994 to 2024
$5.1M
Sequences controlling H19 Gene ImprintingR37GM051279 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 2011 to 2020
$3.9M
Control of developmental switch of Cyp3a gene expression in mouse liverR01GM087376 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ZHONG, XIAO-BO · 2010 to 2014
$1.5M
NIGMS NIH HHS GM51279NIGMS NIH HHS R01 GM051279NIGMS NIH HHS R01 GM087376NIGMS NIH HHS R37 GM051279
6 · The paper itself

Abstract

The epigenetic regulation of imprinted genes by monoallelic DNA methylation of either maternal or paternal alleles is critical for embryonic growth and development. Imprinted genes were recently shown to be expressed in mammalian adult stem cells to support self-renewal of neural and lung stem cells; however, a role for imprinting per se in adult stem cells remains elusive. Here we show upregulation of growth-restricting imprinted genes, including in the H19-Igf2 locus, in long-term haematopoietic stem cells and their downregulation upon haematopoietic stem cell activation and proliferation. A differentially methylated region upstream of H19 (H19-DMR), serving as the imprinting control region, determines the reciprocal expression of H19 from the maternal allele and Igf2 from the paternal allele. In addition, H19 serves as a source of miR-675, which restricts Igf1r expression. We demonstrate that conditional deletion of the maternal but not the paternal H19-DMR reduces adult haematopoietic stem cell quiescence, a state required for long-term maintenance of haematopoietic stem cells, and compromises haematopoietic stem cell function. Maternal-specific H19-DMR deletion results in activation of the Igf2-Igfr1 pathway, as shown by the translocation of phosphorylated FoxO3 (an inactive form) from nucleus to cytoplasm and the release of FoxO3-mediated cell cycle arrest, thus leading to increased activation, proliferation and eventual exhaustion of haematopoietic stem cells. Mechanistically, maternal-specific H19-DMR deletion leads to Igf2 upregulation and increased translation of Igf1r, which is normally suppressed by H19-derived miR-675. Similarly, genetic inactivation of Igf1r partly rescues the H19-DMR deletion phenotype. Our work establishes a new role for this unique form of epigenetic control at the H19-Igf2 locus in maintaining adult stem cells.

Indexed as

Genomic ImprintingAdult Stem CellsAnimalsEpigenesis, GeneticGene Expression Regulation, DevelopmentalInsulin-Like Growth Factor IIMiceReceptor, IGF Type 1RNA, Long NoncodingSignal TransductionTranscriptional ActivationH19 long non-coding RNAIGF2 protein, mouseInsulin-Like Growth Factor IIReceptor, IGF Type 1RNA, Long Noncoding

Identifiers

PMID23863936
PMCPMC3896866
OpenAlexW2081038378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.